HOW AI IS CHANGING THE DIAGNOSIS AND CARE OF RARE DISEASES
Healthcare Radius
|August 2025
In hospitals, labs, and research centers around the world, artificial intelligence (AI) is transforming the way doctors diagnose and treat rare diseases.
Collectively, these conditions affect more than 350 million people globally, yet they remain undetected for years, with patients suffering from symptoms that are misunderstood, misdiagnosed, or ignored. AI is becoming an increasingly useful ally, recognizing elusive patterns, accelerating diagnoses, and facilitating the creation of tailored treatments that seemed impossible until now.
The Singular Challenge of Rare Diseases
Rare diseases are characterized by their low incidence, but as a collective group, they are substantial. Since more than 7,000 rare diseases exist, the vast majority of those affected have long, exasperating odysseys to the correct diagnosis. Rare diseases often present similarly to more frequent ailments, so early detection is challenging with conventional diagnostic techniques. Too often, patients see several specialists, receive a battery of tests, and spend years trying to get an answer. For instance, Ehlers-Danlos syndrome (EDS), a collection of connective tissue disorders, is usually confused with fibromyalgia or psychosomatic pain. Likewise, Fabry disease is usually misdiagnosed as rheumatoid arthritis or gastrointestinal pathology. These delays in diagnosis may result in irreversible complications that range from organ damage to child developmental delay.
Traditional medicine, even with high-tech testing, finds it difficult to provide quick and accurate results. This is where Al promises a ray of hope.
The Potential of Al in Diagnosing Rare Diseases
Quick and Knowledgeable Diagnoses
Al is able to analyze and process enormous amounts of data, from clinical narratives and symptoms to genetic and imaging reports, and spot connections among apparently unrelated bits of information. By highlighting connections that might not be apparent at first glance, Al reduces the amount of time spent thinking about and verifying rare disease diagnoses.
Bu hikaye Healthcare Radius dergisinin August 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Healthcare Radius'den DAHA FAZLA HİKAYE
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Listen
Translate
Change font size

